this is crazy blue sky stuff but you are right. Despite what...

this is crazy blue sky stuff but you are right. Despite what Sessions is saying publicly (not that he is likely to be there much longer), as I understand it FDA are watching the trials of products globally and if anything comes up that looks like a potential help with Opiods crisis in the US the upside would be very signiifcant.

The big Canadian names are capped in the 4-6 BIllion range but that is based on recreational prodpects

Read the New Yorker aritcle on Oxicodyn to get some perspective on opportunity in the US if pain management is approved by FDA

https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain